Some of the stocks that may grab investor focus today are:
- Wall Street expects Home Depot Inc (NYSE: HD) to
report quarterly earnings at $1.81 per share on revenue of $24.46 billion before the opening bell. Home Depot shares gained 1
percent to $167.00 in after-hours trading.
- Analysts expect L Brands Inc (NYSE: LB) to post
quarterly earnings at $0.29 per share on revenue of $2.57 billion after the closing bell. L Brands shares declined 1.43 percent
to close at $48.95 on Monday.
-
Buffalo Wild Wings (NASDAQ: BWLD) shares climbed
around 28 percent in after-hours trading on a $2.3 billion takeover bid submitted by private-equity firm Roark Capital. The
firm’s bid for the restaurant chain is worth over $150 per share. Buffalo Wild Wings shares jumped 27.93 percent to $150.00 in
the after-hours trading session.
- Before the opening bell, Dicks Sporting Goods Inc (NYSE: DKS) is projected to report quarterly earnings at $0.27 per share on revenue of
$1.89 billion. Dicks Sporting shares declined 0.08 percent to $26.30 in after-hours trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- Analysts are expecting TJX Companies Inc (NYSE: TJX) to have earned $1 per share on revenue of $8.87 billion in the latest quarter.
TJX will release earnings before the markets open. TJX shares slipped 0.23 percent to $70.60 in after-hours trading.
-
Switch Inc (NYSE: SWCH) shares dropped over 7
percent in after-hours trading despite beating
top and bottom estimates in the third quarter, its first earnings release as a public company. The company posted Q3 EPS of
8 cents, just beating estimates by a penny. Revenues came in nearly $2 million ahead of estimates at $97.7 million. Switch
shares declined 7.29 percent to $18.57 in the after-hours trading session.
- After the markets close, Advance Auto Parts, Inc. (NYSE: AAP) is expected to post quarterly earnings at $1.24 per share on revenue of $2.22
billion. Advance Auto Parts shares gained 0.09 percent to $82.35 in after-hours trading.
-
TRACON Pharmaceuticals Inc (NASDAQ: TCON)
disclosed positive results from a Phase 1 trial of TRC102 and Fludara in Patients with advanced Hematologic Malignancy. TRACON
Pharmaceuticals shares surged 17.86 percent to $3.30 in the after-hours trading session.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.